This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of our products and services, assist with our promotional and marketing efforts, and provide content from third parties. Read our cookie policy.
Patient Care
We deliver high-quality care with innovation and empathy.
We deliver high-quality care with innovation and empathy.
PRACTICE SUPPORT
Products
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Insights
Our Company
More
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Fresenius Health Partners, InterWell Health, and Cricket Health are coming together to create the new standard in value based kidney care in the U.S., driving innovation and transforming the healthcare industry. Visit TransformingKidneyCare.com for more information.
Chief Clinical Officer
Kelly Bemis is a registered nurse who has been with National Cardiovascular Partners since August 2013. She is one of the veterans within the executive team and continues to bring her knowledge and experience to the company to ensure that NCP continues to be a compliant and profitable organization.
Kelly has served as chief clinical officer since February 2017, using her skills in both clinical and business settings to optimize the company's performance.
Prior to joining NCP, Kelly worked for Surgical Care Affiliates. She received her bachelor of science in nursing from Old Dominion University.
Kelly currently lives in San Diego, California.
© 2006-2022 Fresenius Medical Care. All Rights Reserved